Millennium Management’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,000
Closed -$13K 6682
2024
Q3
$13K Buy
+16,000
New +$17.8K ﹤0.01% 5843
2023
Q4
Sell
-11,504
Closed -$61.7K 6694
2023
Q3
$61.7K Sell
11,504
-15,364
-57% -$58K ﹤0.01% 5442
2023
Q2
$88.9K Sell
26,868
-1,592
-6% -$6.71K ﹤0.01% 5353
2023
Q1
$156K Sell
28,460
-2,811
-9% -$19.1K ﹤0.01% 5271
2022
Q4
$156K Sell
31,271
-8,377
-21% -$45.8K ﹤0.01% 5423
2022
Q3
$221K Sell
39,648
-11,059
-22% -$119K ﹤0.01% 5595
2022
Q2
$447K Buy
50,707
+46,389
+1,074% +$471K ﹤0.01% 5054
2022
Q1
$67K Sell
4,318
-30,310
-88% -$525K ﹤0.01% 6307
2021
Q4
$919K Buy
34,628
+14,908
+76% +$566K ﹤0.01% 4487
2021
Q3
$961K Sell
19,720
-4,387
-18% -$271K ﹤0.01% 4734
2021
Q2
$2.03M Buy
24,107
+19,075
+379% +$1.64M ﹤0.01% 3939
2021
Q1
$510K Buy
+5,032
New +$553K ﹤0.01% 4810

Other funds holding AWH

Millennium Management's AWH Position: Q4 2024 in Review

Millennium Management sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2024, closing a stake of 16,000 shares — an estimated $13K sold.

Millennium Management first reported a position in AWH in Q1 2021 and held it in 12 quarters. The position peaked at $2.03M in Q2 2021. 26 funds tracked by Wall St. Rank hold AWH as of Q4 2024.

  • Millennium Management reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Millennium Management sold 16,000 Aspira Women's Health Inc. Common Stock shares in Q4 2024, an estimated $13K.
  • Millennium Management first reported a position in Aspira Women's Health Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Millennium Management's Aspira Women's Health Inc. Common Stock position peaked at $2.03M in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.